Mayne Pharma Group Ltd (ASX:MYX)
A$ 5.1 0.67 (15.12%) Market Cap: 433.88 Mil Enterprise Value: 323.42 Mil PE Ratio: 0 PB Ratio: 0.91 GF Score: 74/100

Half Year 2021 Mayne Pharma Group Ltd Earnings Presentation Transcript

Feb 23, 2021 / 10:00PM GMT
Release Date Price: A$6.2
Operator

Presentation
Feb 23, 2021 / 10:00PM GMT

=====================
Corporate Participants
=====================
* Peter Paltoglou
Mayne Pharma Group Limited - CFO
* Scott Anthony Richards
Mayne Pharma Group Limited - MD, CEO & Executive Director

=====================
Conference Call Participants
=====================
* Gretel Janu
Crédit Suisse AG, Research Division - Research Analyst
* John Deakin-Bell
Citigroup Inc. Exchange Research - Research Analyst
* John Hester
Bell Potter Securities Limited, Research Division - Senior Healthcare Equities Analyst
* Saul Hadassin
UBS Investment Bank, Research Division - Executive Director & Research Analyst

=====================

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot